Anatol Kreitzer Insider Trades & Stock Holdings

Chief Discovery Officer · MapLight Therapeutics, Inc. · Latest filing Oct 15, 2026

Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, Inc. has 1 Form 4 trade on file since Oct 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($96.02K), net -$96.02K. Latest filing: disposed of 12.25K shares of $MPLT on Oct 15, 2026 at $7.84.

Trades on file

1

Open-market bought

$0

Open-market sold

$96.02K

Net open-market

-$96.02K

Shares held ($MPLT)

168.68K

Latest filing

Oct 15, 2026

Shares held by Anatol Kreitzer

• $MPLT168.68K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Anatol Kreitzer

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 15, 2026	$MPLT	Sell (Open-market sale)	12.25K	$7.84	$96.02K	168.68K	-6.77%				Chief Discovery Officer	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Anatol Kreitzer traded

• $MPLT

Frequently asked questions

Has Anatol Kreitzer been buying or selling stock?

Anatol Kreitzer has 0 open-market purchases and 1 open-market sale on file, net -$96.02K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Anatol Kreitzer's latest insider trade?

disposed of 12.25K shares of $MPLT on Oct 15, 2026 at $7.84.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.